Litenimod (sodium)
Litenimod sodium is potent type B agonist of toll Like receptor 9 (TLR9), triggering both innate and adaptive immune response.
Product Specifications
Product Name Alternative
Li28 sodium (sodium)
UNSPSC
12352208
Target
Toll-like Receptor (TLR)
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
[Litenimod(sodium)]
References & Citations
[1]Schaedler E, Remy-Ziller C, Hortelano J, et al. Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors. Vaccine. 2017;35 (4) :577-585.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
JOT-EK2032Mo 96 wells
Mouse dolichyl-diphosphooligosaccharide-protein glycosyltransferase, DDOST; OST-48 ELISA KIT
Sign In for Pricing
View Details 